Top results
© paracelsus medizinische privatuniversität | institute of molecular regenerative medicine | ludwig aigner rejuvenation of the aged brain an example of drug delivery…
© paracelsus medizinische privatuniversität institute of molecular regenerative medicine ludwig aigner rejuvenation of the aged brain an example of drug delivery in drug…
we make approved drugs better tsx-v: igx otcqx: igxt leader in pharmaceutical oral films our mission we make approved drugs better, with next generation pharmaceutical products…
1. innovation in drug delivery an introduction to unique pharmaceutical delivery technologies may 2015 tsx-v: igx otcqx: igxt 2. forward looking statements to the extent…
1. innovative drug delivery september 2014 confidential - intelgenx corp. innovative drug delivery 1 2. forward looking statement to the extent any statements made in this…
0 investor presentation aug 11, 2016 innovative drug delivery solutions 1 2 to the extent any statements made in this presentation contain information that is not historical,…
innovation in drug delivery innovation in drug delivery an introduction to unique pharmaceutical delivery technologies january 2015 tsx-v: igx otcqx: igxt igxt is a company…
united states securities and exchange commission washington, d.c. 20549 form 8-k current report pursuant to section 13 or 15d of the securities and exchange act of 1934 september…
0 investor presentation june 17, 2016 innovative drug delivery solutions 1 2 to the extent any statements made in this presentation contain information that is not historical,…
0 investor presentation may 20, 2016 innovative drug delivery solutions 1 2 to the extent any statements made in this presentation contain information that is not historical,…
0 investor presentation april 7, 2016 innovative drug delivery solutions 1 2 to the extent any statements made in this presentation contain information that is not historical,…
0 conference call & webcast march 23, 2016 q4 & full year 2015 financial results 1 2 to the extent any statements made in this presentation contain information that…
ddt cover/back april 2006.qxinterview with intelgenx technologies’ derek g. hennecke, mba mucoadhesion enhancement 40 rita j. majithiya, mpharm amit j. raval, mpharm
folie 1 optimale histogramme daniel aigner [email protected] folie 2 1 was sind histogramme? (1) daten von 1500 befragten in 6 balken was, wenn man das alter…
0 tsx-v: igx otcqx: igxt we make approved drugs better investor presentation november 2017 innovative drug delivery solutions 1 2 to the extent any statements made in this…
1. 0 tsx-v: igx otcqx: igxt we make approved drugs better investor presentation november 2017 innovative drug delivery solutions 2. 1 2 to the extent any statements made…
kennung ampas amann paul bechs benz christian boers botz ernst dahes daschner herbert ebbr ebner brigitte mail: [email protected] eijos eidenschink josef enlus engel…
filed pursuant to rule 424b3 registration no 333-190065 prospectus supplement no 1 to prospectus dated april 15 2016 intelgenx technologies corp up to 7231123 shares of common…
0 investor presentation march 30, 2017 innovative drug delivery solutions 1 2 to the extent any statements made in this presentation contain information that is not historical,…
0 investor presentation july 6, 2016 innovative drug delivery solutions 1 2 to the extent any statements made in this presentation contain information that is not historical,…